期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

干细胞治疗心脏疾患研究进展 被引量：2

Advances on stem cells in the treatment of cardiac diseases
下载PDF
导出
摘要 随着再生医学研究的深入,干细胞移植已用于临床实验。目前成骨骼肌细胞、骨髓源性干细胞、间充质干细胞和心肌固有干细胞已应用于心肌再生治疗。其中C-kit阳性心肌干细胞移植,不仅对收缩性心力衰竭有明确疗效,而且从长远来看,无明显不良事件发生。现就与心肌再生相关细胞作一综述,阐述何类细胞更适于心脏疾患的治疗。 Various researches on regenerative medicine were carried out experimentally, and selected modalities have been introduced to the clinical arena. So far skeletal myoblasts, bone marrow-derived cells, mesenchymal stromal cells, and resident cardiac cells have been applied for therapeutic myocardial regeneration. Among them, autologous transplantation of c-kit-positive cardiac stem cells in congestive heart failure patients resulted in an outstanding outcome, with long-lasting beneifcial effects without major adverse events. By reviewing these clinical trials, an endeavor was made to seek for an ideal cellular therapy for cardiovascular diseases.
作者 瞿海龙 麻月云 边剑飞
机构地区 河北大学附属医院急诊科 保定市妇幼保健院
出处 《医学研究与教育》 CAS 2014年第5期55-58,共4页 Medical Research and Education
关键词 再生医学 干细胞 心肌梗死 regenerative medicine stem cells myocardical infarction
分类号 R542.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献15

  • 1BELTRAMI A P, BARLUCCHI L, TORELLA D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration[J]. Cell, 2003, 114(6): 763-776.
  • 2BERGMANN O, BHARDWAJ R D, BERNARD S, et al. Evidence for cardiomyocyte renewal in humans[J]. Science, 2009, 324(5923): 98-102.
  • 3MENASCHE P, HAGEGE A A, SCORSIN M, et al. Myoblast transplantation for heart failure[J]. Lancet, 2001, 357(9252): 279- 280.
  • 4MENASCHP, ALFIERI O, JANSSENS S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation[J]. Circulation, 2008, 117(9): 1189-1200.
  • 5SCHACHINGER V, ERBS S, ELSASSER A, et al. Intracoronary bone marrow-derived progenitor cells in acute myoeardial infarction[J]. N Engl J Med, 2006, 355(12): 1210-1221.
  • 6IEEVANANTHAM V, BUTLER M, SAAD A, et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis[J]. Circulation, 2012, 126(5): 551- 568.
  • 7瞿海龙,边剑飞,张冰,王颖,周英莲.间充质干细胞临床应用的前景与困惑[J].医学研究与教育,2011,28(5):72-75. 被引量：7
  • 8HARE J M, TRAVERSE J H, HENRY T D, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells(prochymal)after acute myocardial infarction[J]. J Am Coil Cardiol, 2009, 54(24): 2277-2286.
  • 9HARE J M, FISHMAN J E, GERSTENBLITH G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial[J]. JAMA, 2012, 308(22): 2369-2379.
  • 10BEARZI C, ROTA M, HOSODA T, et al. Human cardiac stem cells[J]. Proc Natl Acad Sci U S A, 2007, 104(35): 14068-14073.

二级参考文献31

  • 1孟玲,刘国树,曹丰,牛丽丽,高艳红,张鹏,赵连旭,李艳华,裴雪涛.经静脉途径移植骨髓间充质干细胞修复梗死心肌的可行性与安全性研究[J].中华老年心脑血管病杂志,2005,7(3):184-187. 被引量：7
  • 2姚康,黄榕翀,葛雷,钱菊英,李延林,徐世坤,张峰,章轶琦,牛玉宏,史剑慧,张少衡,樊冰,王齐冰,孙爱军,邹云增,葛均波.经冠状动脉自体骨髓单个核细胞移植治疗急性心肌梗死的安全性观察[J].中华心血管病杂志,2006,34(7):577-581. 被引量：16
  • 3PATEL S A,MEYER J R,GRECO S J,et al.Mesenchymal stem cells protect breast cancer cells through regulatory T cells:role of mesenchymal stem cell-derived TGF-β[J].Journal of Immunology,2010,184(10):5885-5894.
  • 4FRIEDENSTEIN A J,PIATETZKY-SHAPIRO I I,PETRAKOVA K V.Osteogenesis in transplants of bone marrow cells[J].Journal of Embryology and Experimental Morphology,1966,16(3):381-390.
  • 5DOMINICI M,LE BLANC K,MUELLER I,et al.Minimal criteria for defining multipotent mesenchymal stromal cells:the international society for cellular therapy position statement[J].Cytotherapy,2006,8(4):315-317.
  • 6LAZARUS H M,HAYNESWORTH S E,GERSON S L,et al.Exvivo expansion and subsequent infusion of human bone marrowderived stromal progenitor cells (mesenchymal progenitor cells):implications for therapeutic use[J].Bone Marrow Transplantation,1995,16(4):557-564.
  • 7HORWITZ E M,PROCKOP D J,FITZPATRICK L A,et al.Transplantability and therapeutic effects of hone marrow-derived mesenchymal cells in children with osteogenesis imperfecta[J].Nature Medicine,1999,5(3):309-313.
  • 8LE BLANC K,RASMUSSON I,SUNDBERG B,et al.Treatment of severe acute graft-versus-host disease with third party hanloidentical mesenchvmal stem cells[J].Lancet,2004,363(9419):1439-1441.
  • 9YOON S H,SHIM Y S,PARK Y H,et al.Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor:phase Ⅰ/Ⅱ clinical trial[J].Stem Cells,2007,25(8):2066-2073.
  • 10CARR K,STEELE D,STEELE S,et al.l-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence[J].International Urogynecology Journal and Pelvic Floor Dysfunction,2008,19(6):881-883.

共引文献24

同被引文献28

  • 1Umberto Galderisi,Antonio Giordano,Marco G Paggi.The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents[J].World Journal of Stem Cells,2010,2(1):5-12. 被引量：3
  • 2GO A S, MOZAFFARIAN D, ROGER V L, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association[J]. Circulation, 2013, 127( 1): e6-e245.
  • 3LOZANO R, NAGHAVI M, FOREMAN K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2013, 381(9867): 628.
  • 4FUTAKUCHI-TSUCHIDA A, MURRY C E. Human myocardial grafts: do they meet all the criteria for true heart regeneration? [J] Future Cardiol, 2013, 9(2): 151-154.
  • 5STRAUER BE, BREHM M, ZEUS T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans[J]. Circulation, 2002, 106(15): 1913-1918.
  • 6MALLIARAS K, MARBAN E. Cardiac cell therapy: where we've been, where we are, and where we should be headed[J]. Br Med Bull, 2011, 98(1): 161-185.
  • 7WOLLERT K C, MEYER G P, LOTZ J. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial[J]. Lancet, 2004, 364(9429): 141-148.
  • 8MEYER G P, WOLLERT K C, LOTZ J, et al. Intracoronary bane marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial[J]. Circulation, 2006, 113(10): 1287-1294.
  • 9SCHACHINGER V, ERBS S, ELSASSER A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction[J]. N Engl J Med, 2006, 355(12): 1210-1221.
  • 10LEISTNER D M, FISCHER-RASOKAT U, HONOLD J, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy[J]. Clin Res Cardiol, 2011, 100(10): 925-934.

引证文献2

二级引证文献3

医学研究与教育
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部